Cargando…
Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients
Immunotherapy approaches using checkpoint blockade, alone, or in combination with tumor antigen vaccination, or adoptive cell transfer, are emerging as promising approaches for the treatment of non-small cell lung cancer (NSCLC). In preparation for upcoming combined immunotherapy approaches in NSCLC...
Autores principales: | Saito, Kanako, Nakayama, Eiichi, Valmori, Danila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777370/ https://www.ncbi.nlm.nih.gov/pubmed/26937656 http://dx.doi.org/10.1371/journal.pone.0150623 |
Ejemplares similares
-
Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients
por: Sardaro, Alessandro, et al.
Publicado: (2016) -
Cancer testis antigen XAGE-1 is a promising marker for the diagnosis and treatment of ovarian cancer
por: Jumaa, Maysaa Ghazi, et al.
Publicado: (2021) -
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2015) -
Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy
por: Tarek, Mohammad M., et al.
Publicado: (2018) -
Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity
por: Saito, Kanako, et al.
Publicado: (2015)